• LB Pharmaceuticals appointed Joseph Miller as chief financial officer.
• Miller previously served as CFO of Aurinia Pharmaceuticals, overseeing the buildout of finance operations through the commercial launch of LUPKYNIS.
• He also held CFO, principal executive officer, corporate secretary roles at Avalo Therapeutics, leading acquisitions and a divestiture of its commercial portfolio.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. LB Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-381076), on September 03, 2026, and is solely responsible for the information contained therein.